Ryvu Therapeutics SA (RVU) — Cash Flow Quality Index
Ryvu Therapeutics SA (RVU) has a Cash Flow Quality Index of -0.22x as of March 2018. Operating cash flow of zł-4.33 Million is below net income of zł19.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore RVU long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ryvu Therapeutics SA Cash Flow Quality Index (2014–2018)
Historical Cash Flow Quality Index for Ryvu Therapeutics SA across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Ryvu Therapeutics SA (RVU) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Ryvu Therapeutics SA (2014–2018)
Year-by-year earnings quality comparison for Ryvu Therapeutics SA. For live market cap and the full company financial profile, see Ryvu Therapeutics SA (RVU) total market value.
| Year | Quality Index | Operating CF (PLN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | -40.80x | zł-36.42 Million | zł892.48K | ▼ -2601.3% |
| 2017 | 1.63x | zł10.98 Million | zł6.73 Million | ▲ +169.8% |
| 2016 | -2.34x | zł-6.28 Million | zł2.69 Million | ▲ +11.3% |
| 2015 | -2.64x | zł-16.43 Million | zł6.23 Million | ▼ -214.6% |
| 2014 | -0.84x | zł-4.90 Million | zł5.85 Million | — |